Shares of Tilray Inc (NASDAQ:TLRY - Get Free Report) were down 1.6% during mid-day trading on Thursday . The company traded as low as $1.51 and last traded at $1.52. Approximately 11,205,902 shares were traded during trading, a decline of 56% from the average daily volume of 25,275,756 shares. The stock had previously closed at $1.54.
Analyst Ratings Changes
Separately, Roth Mkm cut their price objective on Tilray from $2.00 to $1.75 and set a "neutral" rating on the stock in a report on Friday, October 11th.
Check Out Our Latest Stock Analysis on TLRY
Tilray Trading Up 0.3 %
The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57. The company has a market cap of $1.40 billion, a price-to-earnings ratio of -5.61 and a beta of 2.14. The business's fifty day moving average price is $1.68 and its 200 day moving average price is $1.79.
Tilray (NASDAQ:TLRY - Get Free Report) last issued its quarterly earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.04). Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The firm had revenue of $200.00 million for the quarter, compared to the consensus estimate of $218.70 million. During the same quarter in the previous year, the company earned ($0.10) EPS. The company's revenue for the quarter was up 13.0% on a year-over-year basis. Research analysts anticipate that Tilray Inc will post -0.14 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Tilray
Hedge funds have recently added to or reduced their stakes in the business. Ferguson Wellman Capital Management Inc. acquired a new stake in shares of Tilray during the 3rd quarter worth approximately $26,000. HBK Sorce Advisory LLC bought a new stake in Tilray in the first quarter valued at $37,000. Prospect Financial Services LLC acquired a new position in shares of Tilray during the second quarter valued at about $26,000. Signature Estate & Investment Advisors LLC bought a new position in shares of Tilray during the 2nd quarter worth about $29,000. Finally, Jeppson Wealth Management LLC acquired a new stake in shares of Tilray in the 2nd quarter valued at about $33,000. 9.35% of the stock is currently owned by institutional investors.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
